Clinical Trials Directory

Trials / Sponsors / Fundacion CRIS de Investigación para Vencer el Cáncer

Fundacion CRIS de Investigación para Vencer el Cáncer

Academic / Other · 7 registered clinical trials.

StatusTrialPhaseStarted
TerminatedReduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS
Diffuse Large B-Cell Lymphoma, Drug Toxicity
Phase 22021-07-19
CompletedRogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.
Breast Cancer Metastatic, Hormone Receptor Positive Malignant Neoplasm of Breast
Phase 12020-11-25
Active Not RecruitingStudy to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)
Chronic Myeloid Leukemia, Chronic Phase
Phase 22020-01-17
CompletedNiraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA)
Urothelial Cancer
Phase 1 / Phase 22019-10-14
CompletedDurvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO)
Bladder Cancer
Phase 22018-10-25
CompletedSkin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA)
Skin Toxicity
Phase 22018-05-10
CompletedDifferential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)
Immune Thrombocytopenia, Myelodysplastic Syndromes
—2018-04-25